Profitable Growth - in full compliance!



The overall business focus of SOLVING is the pragmatic and hands-on support of our customers in systematically identifying and exploiting growth potentials - always respecting superior compliance and ethical standards (growth with full integrity)

 

We have developed a very specific approach that leads to a rapid time to benefit, tangible and lasting top-and bottom-line impact.

 

All our concepts and initiatives will be put to the compliance and ethical acid test by us or our (legal) partners.

All enabling areas will be aligned with the critical success factors.

 

Our profound and - market-wise - since the beginning of the 2000+ years highly acknowledged compliance-competency guarantees high ethical and legal/compliance standards of project results.

Our international and operative experience assures that the project-results and initiatives can and will be implemented and are easily accepted in the organization.

Due to  considerable number of projects in the area of compliance, medical, marketing and sales we are qualified to deliver holistic solutions and results which meet - at any time - high ethical, medical and scientific requirements.


PharmaTimes: News RSS

AZ’s Saphnelo scores US approval for systemic lupus erythematosus (Mo, 02 Aug 2021)
Saphnelo is the first type I interferon receptor agonist to receive regulatory approval
>> mehr lesen

EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients (Mon, 02 Aug 2021)
The approval is based on Phase III results from the CheckMate-577 trial
>> mehr lesen

UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis (Mon, 02 Aug 2021)
Bimekizumab is the first to follow NICE’s new expedited appraisal process
>> mehr lesen